Edesa Biotech (EDSA) Inventory Average (2015 - 2019)
Edesa Biotech (EDSA) posted Inventory Average of $160942.5 for Q2 2019, down 30.29% sequentially from $230880.5 in Q3 2018, and down 27.32% YoY from $221429.0 in Q2 2018.
Edesa Biotech (EDSA) Inventory Average (2015 - 2019) Analysis & Trends
Edesa Biotech has reported Inventory Average for 5 years, with the latest figure at $160942.5 in Q2 2019.
- Quarterly Inventory Average fell 27.32% year-over-year to $160942.5 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $160942.5 (down 27.32% YoY) and the FY2018 annual result came in at $146190.5, down 7.92% from the prior year.
- Inventory Average eased to $160942.5 in Q2 2019 per EDSA's latest filing, from $230880.5 in the prior quarter.
- Over five years, Inventory Average peaked at $556080.5 in Q2 2016 and troughed at $93327.0 in Q4 2017.
- A 5-year average of $282949.6 and a median of $228320.5 in 2017 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2016 and 2017: Inventory Average jumped 297.62% in 2016, then sank 74.45% in 2017.
- Over 5 years, Inventory Average stood at $542619.0 in 2015, then slumped by 46.65% to $289506.5 in 2016, then plunged by 67.76% to $93327.0 in 2017, then jumped by 147.39% to $230880.5 in 2018, then sank by 30.29% to $160942.5 in 2019.
- According to Business Quant data, Inventory Average over the past three periods registered $160942.5, $230880.5, and $221429.0 for Q2 2019, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 160,942.50 |
| Sep 30, 2018 | 230,880.50 |
| Jun 30, 2018 | 221,429.00 |
| Mar 31, 2018 | 161,952.00 |
| Dec 31, 2017 | 93,327.00 |
| Sep 30, 2017 | 104,530.50 |
| Jun 30, 2017 | 225,760.50 |
| Mar 31, 2017 | 320,078.50 |
| Dec 31, 2016 | 289,506.50 |
| Sep 30, 2016 | 409,064.00 |
| Jun 30, 2016 | 556,080.50 |
| Mar 31, 2016 | 535,710.50 |
| Dec 31, 2015 | 542,619.00 |
| Sep 30, 2015 | 375,823.50 |
| Jun 30, 2015 | 164,759.00 |
| Mar 31, 2015 | 134,729.50 |